Supposing a definitive model that can emulate the AQP4 changes in acute MS lesions is identified, AQP4 modulating interventions may be assessed to determine their impact on acute MS flares and subsequent progression to chronic lesions. The gene discussed is AQP4; the disease is myeloid sarcoma.